| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule minus-end binding | 4.55e-05 | 15 | 95 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 3.39e-04 | 363 | 95 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | AKT3 ERBB4 OBSCN HIPK2 LMTK2 DAPK3 RET CDKL5 MAP3K9 PIP5K1A AKT1 | 5.44e-04 | 709 | 95 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | 5.68e-04 | 600 | 95 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 6.11e-04 | 35 | 95 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 9.83e-04 | 10 | 95 | 2 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 9.83e-04 | 10 | 95 | 2 | GO:0070740 | |
| GeneOntologyMolecularFunction | kinase activity | AKT3 ERBB4 OBSCN HIPK2 LMTK2 DAPK3 RET CDKL5 MAP3K9 PIP5K1A AKT1 | 1.00e-03 | 764 | 95 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.05e-03 | 42 | 95 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.20e-03 | 11 | 95 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.30e-03 | 446 | 95 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AKT3 ERBB4 TENT4A OBSCN HIPK2 LMTK2 DAPK3 RET CDKL5 MAP3K9 PIP5K1A AKT1 | 1.62e-03 | 938 | 95 | 12 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.64e-03 | 49 | 95 | 3 | GO:0005547 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.69e-03 | 13 | 95 | 2 | GO:0098879 | |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B ERBB4 ANK3 DSCAM CACNA2D2 CARMIL3 PCLO PKP4 DAPK3 GRHL2 CDKL5 DST SHANK2 PTPRJ TJP1 PIP5K1A AKT1 OCLN GABRA4 TJP3 | 3.70e-08 | 974 | 100 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | ERBB4 DSCAM CARMIL3 PCLO PKP4 DAPK3 GRHL2 DST SHANK2 PTPRJ TJP1 PIP5K1A OCLN GABRA4 | 6.30e-07 | 569 | 100 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of blood-brain barrier permeability | 1.10e-06 | 5 | 100 | 3 | GO:1905605 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 6.98e-06 | 426 | 100 | 11 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of blood-brain barrier permeability | 1.29e-05 | 10 | 100 | 3 | GO:1905603 | |
| GeneOntologyBiologicalProcess | eye development | 2.12e-05 | 480 | 100 | 11 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 2.25e-05 | 483 | 100 | 11 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 2.61e-05 | 491 | 100 | 11 | GO:0048880 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 4.98e-05 | 269 | 100 | 8 | GO:0002064 | |
| GeneOntologyBiologicalProcess | maintenance of blood-brain barrier | 5.05e-05 | 42 | 100 | 4 | GO:0035633 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PLXNA3 ROBO4 RBM15 AKT3 DSCAM SOX30 OBSCN HIPK2 RET GRHL2 HOXA5 BMP4 PTPRJ TJP1 ARMC5 CSPG4 AKT1 GAB1 CDON | 8.17e-05 | 1483 | 100 | 19 | GO:0048646 |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 8.44e-05 | 148 | 100 | 6 | GO:1902414 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell differentiation | 1.01e-04 | 19 | 100 | 3 | GO:0060644 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.23e-04 | 228 | 100 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | tube development | ROBO4 RBM15 AKT3 NAGLU NUMA1 HIPK2 RET GRHL2 ALX4 HOXA5 BMP4 PTPRJ ATXN1 TJP1 LOX CSPG4 AKT1 GAB1 | 1.26e-04 | 1402 | 100 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 1.46e-04 | 103 | 100 | 5 | GO:0002088 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | ROBO4 RBM15 AKT3 NAGLU HIPK2 HOXA5 BMP4 PTPRJ TJP1 LOX CSPG4 AKT1 GAB1 | 1.59e-04 | 817 | 100 | 13 | GO:0048514 |
| GeneOntologyBiologicalProcess | positive regulation of vascular permeability | 1.82e-04 | 23 | 100 | 3 | GO:0043117 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.86e-04 | 171 | 100 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 2.20e-04 | 61 | 100 | 4 | GO:0060428 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 2.35e-04 | 25 | 100 | 3 | GO:0016202 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 2.64e-04 | 117 | 100 | 5 | GO:0046785 | |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 2.98e-04 | 66 | 100 | 4 | GO:0031122 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | ROBO4 RBM15 AKT3 NAGLU HIPK2 RET GRHL2 HOXA5 BMP4 PTPRJ TJP1 LOX CSPG4 AKT1 GAB1 | 3.31e-04 | 1125 | 100 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | lung development | 3.38e-04 | 269 | 100 | 7 | GO:0030324 | |
| GeneOntologyBiologicalProcess | regulation of glomerulus development | 3.45e-04 | 6 | 100 | 2 | GO:0090192 | |
| GeneOntologyBiologicalProcess | embryonic retina morphogenesis in camera-type eye | 3.45e-04 | 6 | 100 | 2 | GO:0060059 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 3.70e-04 | 273 | 100 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 3.94e-04 | 71 | 100 | 4 | GO:0048008 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.94e-04 | 71 | 100 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | regulation of muscle organ development | 4.50e-04 | 31 | 100 | 3 | GO:0048634 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 4.79e-04 | 204 | 100 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | lens induction in camera-type eye | 4.81e-04 | 7 | 100 | 2 | GO:0060235 | |
| GeneOntologyBiologicalProcess | synapse organization | UNC13B ERBB4 ANK3 DSCAM CACNA2D2 CARMIL3 PCLO CDKL5 SHANK2 AKT1 GABRA4 | 4.85e-04 | 685 | 100 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | lung morphogenesis | 5.37e-04 | 77 | 100 | 4 | GO:0060425 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5.44e-04 | 382 | 100 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | blood vessel development | ROBO4 RBM15 AKT3 NAGLU HIPK2 HOXA5 BMP4 PTPRJ TJP1 LOX CSPG4 AKT1 GAB1 | 5.45e-04 | 929 | 100 | 13 | GO:0001568 |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 5.72e-04 | 211 | 100 | 6 | GO:0060041 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB4 NUMA1 HIPK2 LMTK2 RET ERBIN BMP4 PTPRJ ATXN1 LOX CSPG4 SKOR1 FAM83G AKT1 GAB1 | 5.77e-04 | 1186 | 100 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.83e-04 | 139 | 100 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | angiogenesis | ROBO4 RBM15 AKT3 HIPK2 HOXA5 BMP4 PTPRJ TJP1 CSPG4 AKT1 GAB1 | 6.38e-04 | 708 | 100 | 11 | GO:0001525 |
| GeneOntologyBiologicalProcess | respiratory system development | 7.15e-04 | 305 | 100 | 7 | GO:0060541 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CARMIL3 NUMA1 OBSCN DAPK3 TACC2 CEP192 TUBGCP6 FCHSD2 FAT1 TJP1 LOX TUBGCP3 OCLN | 7.19e-04 | 957 | 100 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ANK3 TTLL5 NUMA1 TACC2 CEP192 TUBGCP6 DST TTLL6 TUBGCP3 OCLN TUBD1 | 7.33e-04 | 720 | 100 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of cell size | 8.01e-04 | 225 | 100 | 6 | GO:0008361 | |
| GeneOntologyBiologicalProcess | vasculature development | ROBO4 RBM15 AKT3 NAGLU HIPK2 HOXA5 BMP4 PTPRJ TJP1 LOX CSPG4 AKT1 GAB1 | 8.06e-04 | 969 | 100 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 8.15e-04 | 86 | 100 | 4 | GO:0051898 | |
| GeneOntologyBiologicalProcess | sensory organ development | 8.20e-04 | 730 | 100 | 11 | GO:0007423 | |
| GeneOntologyCellularComponent | anchoring junction | ANK3 PKP4 OBSCN GRHL2 ERBIN FCHSD2 FAT1 DST PTPRJ TJP1 ARMC5 CSPG4 PIP5K1A NHS AKT1 OCLN GAB1 TJP3 | 5.71e-07 | 976 | 98 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | ANK3 PKP4 OBSCN GRHL2 FAT1 DST PTPRJ TJP1 NHS AKT1 OCLN GAB1 TJP3 | 3.85e-06 | 591 | 98 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | cell leading edge | CARMIL3 INPP5E CDKL5 FAT1 DST PTPRJ CSPG4 PIP5K1A NHS AKT1 OCLN GABRA4 | 3.87e-06 | 500 | 98 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.46e-05 | 112 | 98 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.06e-05 | 94 | 98 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.25e-04 | 503 | 98 | 10 | GO:0099572 | |
| GeneOntologyCellularComponent | equatorial microtubule organizing center | 2.16e-04 | 5 | 98 | 2 | GO:0000923 | |
| GeneOntologyCellularComponent | intercalated disc | 2.94e-04 | 68 | 98 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | bicellular tight junction | 3.81e-04 | 131 | 98 | 5 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 5.00e-04 | 139 | 98 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.34e-04 | 141 | 98 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | lamellipodium | 7.53e-04 | 230 | 98 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 7.85e-04 | 523 | 98 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | apical junction complex | 8.93e-04 | 158 | 98 | 5 | GO:0043296 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.06e-03 | 164 | 98 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.16e-03 | 11 | 98 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | microtubule organizing center | NEIL1 TTLL5 NUMA1 TACC2 CEP192 TUBGCP6 CDKL5 TTLL6 TUBGCP3 AKT1 TUBD1 LRIF1 | 1.22e-03 | 919 | 98 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | cell cortex region | 1.23e-03 | 45 | 98 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.28e-03 | 451 | 98 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.82e-03 | 477 | 98 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | dendrite | ERBB4 ANK3 DSCAM KIF21A PCLO NUMA1 RET CDKL5 SHANK2 SKOR1 GABRA4 | 2.26e-03 | 858 | 98 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ERBB4 ANK3 DSCAM KIF21A PCLO NUMA1 RET CDKL5 SHANK2 SKOR1 GABRA4 | 2.30e-03 | 860 | 98 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | DLGAP1 ERBB4 ANK3 CARMIL3 PCLO PKP4 ERBIN CDKL5 DST SHANK2 AKT1 GABRA4 | 2.86e-03 | 1018 | 98 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | ruffle | 2.87e-03 | 206 | 98 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | axon | UNC13B ROBO4 ANK3 DSCAM KIF21A PCLO LMTK2 RET CDKL5 DST SHANK2 | 3.03e-03 | 891 | 98 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | leading edge membrane | 3.11e-03 | 210 | 98 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | supramolecular fiber | ANK3 KIF21A TTLL5 NUMA1 OBSCN STYXL2 DAPK3 TUBGCP6 DST SHANK2 TTLL6 TUBGCP3 TUBD1 | 3.39e-03 | 1179 | 98 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | microtubule | 3.59e-03 | 533 | 98 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | supramolecular polymer | ANK3 KIF21A TTLL5 NUMA1 OBSCN STYXL2 DAPK3 TUBGCP6 DST SHANK2 TTLL6 TUBGCP3 TUBD1 | 3.59e-03 | 1187 | 98 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | gamma-tubulin complex | 4.31e-03 | 21 | 98 | 2 | GO:0000930 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ERBB4 ANK3 DSCAM KIF21A PCLO NUMA1 LMTK2 RET GRM8 CDKL5 SHANK2 SKOR1 GABRA4 | 4.78e-03 | 1228 | 98 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | cell-substrate junction | 4.84e-03 | 443 | 98 | 7 | GO:0030055 | |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B DLGAP1 ERBB4 CARMIL3 PCLO GRM8 ERBIN CDKL5 SHANK2 AKT1 | 4.97e-03 | 817 | 98 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 5.16e-03 | 23 | 98 | 2 | GO:0098831 | |
| Domain | Kinase-like_dom | AKT3 ERBB4 OBSCN HIPK2 LMTK2 CHD9 DAPK3 RET CDKL5 DST MAP3K9 AKT1 | 2.94e-05 | 542 | 99 | 12 | IPR011009 |
| Domain | Protein_kinase_ATP_BS | 3.29e-05 | 379 | 99 | 10 | IPR017441 | |
| Domain | ZO | 8.32e-05 | 3 | 99 | 2 | IPR005417 | |
| Domain | SH3 | 1.52e-04 | 216 | 99 | 7 | PS50002 | |
| Domain | PDZ | 1.53e-04 | 151 | 99 | 6 | PS50106 | |
| Domain | PDZ | 1.58e-04 | 152 | 99 | 6 | IPR001478 | |
| Domain | PROTEIN_KINASE_ATP | 1.61e-04 | 459 | 99 | 10 | PS00107 | |
| Domain | SH3_domain | 1.70e-04 | 220 | 99 | 7 | IPR001452 | |
| Domain | Prot_kinase_dom | 2.68e-04 | 489 | 99 | 10 | IPR000719 | |
| Domain | GCP | 2.75e-04 | 5 | 99 | 2 | IPR007259 | |
| Domain | Spc97_Spc98 | 2.75e-04 | 5 | 99 | 2 | PF04130 | |
| Domain | PROTEIN_KINASE_DOM | 2.86e-04 | 493 | 99 | 10 | PS50011 | |
| Domain | PDZ | 9.25e-04 | 141 | 99 | 5 | PF00595 | |
| Domain | ZU5 | 9.77e-04 | 9 | 99 | 2 | SM00218 | |
| Domain | SH3 | 1.02e-03 | 216 | 99 | 6 | SM00326 | |
| Domain | SH3_2 | 1.13e-03 | 86 | 99 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.13e-03 | 86 | 99 | 4 | PF07653 | |
| Domain | PDZ | 1.15e-03 | 148 | 99 | 5 | SM00228 | |
| Domain | ZU5 | 1.22e-03 | 10 | 99 | 2 | PS51145 | |
| Domain | - | 1.22e-03 | 150 | 99 | 5 | 2.30.42.10 | |
| Domain | fn3 | 1.71e-03 | 162 | 99 | 5 | PF00041 | |
| Domain | PROTEIN_KINASE_TYR | 1.77e-03 | 97 | 99 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.77e-03 | 97 | 99 | 4 | IPR008266 | |
| Domain | ZU5 | 1.77e-03 | 12 | 99 | 2 | PF00791 | |
| Domain | ZU5_dom | 1.77e-03 | 12 | 99 | 2 | IPR000906 | |
| Domain | NCD3G | 2.09e-03 | 13 | 99 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 2.09e-03 | 13 | 99 | 2 | IPR011500 | |
| Domain | TTL | 2.09e-03 | 13 | 99 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 2.09e-03 | 13 | 99 | 2 | IPR004344 | |
| Domain | TTL | 2.09e-03 | 13 | 99 | 2 | PF03133 | |
| Domain | GPCR_3_CS | 2.43e-03 | 14 | 99 | 2 | IPR017979 | |
| Domain | Ser/Thr_kinase_AS | 2.91e-03 | 357 | 99 | 7 | IPR008271 | |
| Domain | S_TKc | 3.00e-03 | 359 | 99 | 7 | SM00220 | |
| Domain | FN3 | 3.05e-03 | 185 | 99 | 5 | SM00060 | |
| Domain | PROTEIN_KINASE_ST | 3.14e-03 | 362 | 99 | 7 | PS00108 | |
| Domain | Ig_I-set | 3.42e-03 | 190 | 99 | 5 | IPR013098 | |
| Domain | ig | 3.42e-03 | 190 | 99 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.42e-03 | 190 | 99 | 5 | IPR013151 | |
| Domain | I-set | 3.42e-03 | 190 | 99 | 5 | PF07679 | |
| Domain | Pkinase | 4.16e-03 | 381 | 99 | 7 | PF00069 | |
| Domain | FN3 | 4.16e-03 | 199 | 99 | 5 | PS50853 | |
| Domain | FN3_dom | 5.11e-03 | 209 | 99 | 5 | IPR003961 | |
| Domain | GPCR_3 | 5.47e-03 | 21 | 99 | 2 | IPR000337 | |
| Domain | 7tm_3 | 6.00e-03 | 22 | 99 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 6.00e-03 | 22 | 99 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 6.00e-03 | 22 | 99 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 6.00e-03 | 22 | 99 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 6.00e-03 | 22 | 99 | 2 | PS50259 | |
| Domain | GPCR_3_C | 6.00e-03 | 22 | 99 | 2 | IPR017978 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.25e-03 | 138 | 99 | 4 | IPR001245 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.22e-06 | 44 | 74 | 5 | MM14520 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 6.13e-06 | 50 | 74 | 5 | M553 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 7.63e-06 | 8 | 74 | 3 | M47715 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 9.58e-06 | 26 | 74 | 4 | MM15501 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.14e-05 | 9 | 74 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.14e-05 | 9 | 74 | 3 | M47490 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.50e-05 | 29 | 74 | 4 | M27756 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 1.62e-05 | 10 | 74 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 2.22e-05 | 11 | 74 | 3 | M47756 | |
| Pathway | REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS | 2.69e-04 | 5 | 74 | 2 | M27791 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 2.69e-04 | 5 | 74 | 2 | M48999 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.14e-04 | 113 | 74 | 5 | MM14783 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 3.31e-04 | 26 | 74 | 3 | M29535 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.84e-04 | 118 | 74 | 5 | M713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 4.02e-04 | 6 | 74 | 2 | M47523 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 4.18e-04 | 67 | 74 | 4 | M295 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 4.60e-04 | 29 | 74 | 3 | M39890 | |
| Pathway | REACTOME_FLT3_SIGNALING | 4.60e-04 | 29 | 74 | 3 | MM15652 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 5.61e-04 | 7 | 74 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 5.61e-04 | 7 | 74 | 2 | M47790 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 6.10e-04 | 74 | 74 | 4 | M39857 | |
| Pathway | KEGG_TIGHT_JUNCTION | 6.41e-04 | 132 | 74 | 5 | M11355 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 6.59e-04 | 367 | 74 | 8 | M48346 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 7.46e-04 | 8 | 74 | 2 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.46e-04 | 8 | 74 | 2 | M47498 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 8.75e-04 | 36 | 74 | 3 | M1315 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47802 | |
| Pathway | WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME | 9.56e-04 | 9 | 74 | 2 | M39879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 9.56e-04 | 9 | 74 | 2 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47972 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.03e-03 | 38 | 74 | 3 | M29803 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.12e-03 | 87 | 74 | 4 | M12467 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.19e-03 | 10 | 74 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 1.19e-03 | 10 | 74 | 2 | M47615 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.19e-03 | 10 | 74 | 2 | MM14956 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.19e-03 | 10 | 74 | 2 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.19e-03 | 10 | 74 | 2 | MM14778 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.21e-03 | 502 | 74 | 9 | MM14537 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.27e-03 | 90 | 74 | 4 | MM14979 | |
| Pathway | WP_ERBB_SIGNALING | 1.38e-03 | 92 | 74 | 4 | M39715 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47499 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.45e-03 | 11 | 74 | 2 | M9990 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.45e-03 | 11 | 74 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M47501 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.55e-03 | 95 | 74 | 4 | M6729 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.73e-03 | 12 | 74 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 1.73e-03 | 12 | 74 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.73e-03 | 12 | 74 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.73e-03 | 12 | 74 | 2 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.73e-03 | 12 | 74 | 2 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.73e-03 | 12 | 74 | 2 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.73e-03 | 12 | 74 | 2 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.73e-03 | 12 | 74 | 2 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.73e-03 | 12 | 74 | 2 | MM14550 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 1.79e-03 | 46 | 74 | 3 | MM15950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 2.04e-03 | 13 | 74 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 2.04e-03 | 13 | 74 | 2 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 2.04e-03 | 13 | 74 | 2 | M549 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 2.37e-03 | 14 | 74 | 2 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.37e-03 | 14 | 74 | 2 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 2.37e-03 | 14 | 74 | 2 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.37e-03 | 14 | 74 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.37e-03 | 14 | 74 | 2 | M47536 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.37e-03 | 14 | 74 | 2 | MM14761 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 2.37e-03 | 14 | 74 | 2 | M3862 | |
| Pathway | REACTOME_APOPTOSIS | 2.48e-03 | 179 | 74 | 5 | M15303 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 2.48e-03 | 108 | 74 | 4 | M48078 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 2.55e-03 | 52 | 74 | 3 | M39782 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 2.65e-03 | 110 | 74 | 4 | M27162 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.73e-03 | 15 | 74 | 2 | M26902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 2.73e-03 | 15 | 74 | 2 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M47971 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.11e-03 | 16 | 74 | 2 | M570 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 3.11e-03 | 16 | 74 | 2 | M29847 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 3.22e-03 | 116 | 74 | 4 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.32e-03 | 117 | 74 | 4 | M39530 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 3.51e-03 | 17 | 74 | 2 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 3.51e-03 | 17 | 74 | 2 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 3.51e-03 | 17 | 74 | 2 | M18895 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 3.66e-03 | 59 | 74 | 3 | M39750 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 3.66e-03 | 59 | 74 | 3 | M48104 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANK3 PKP4 ARHGEF12 TBC1D22B ERBIN CDKL5 DST SHANK2 PTPRJ TJP1 NHS OCLN GAB1 | 1.06e-08 | 565 | 101 | 13 | 25468996 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B PLXNA3 INPP5E NAGLU OBSCN LMTK2 CEP192 BMP4 KMT2C FAT1 DST SHANK2 TULP4 CSPG4 AKT1 DEPDC5 TJP3 | 1.97e-08 | 1105 | 101 | 17 | 35748872 |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 17000770 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RBM15 ERBB4 INPP5E LMTK2 DAPK3 TBC1D22B CEP192 ERBIN DST ATXN1 TJP1 MAP3K9 FAM83G NHS GAB1 | 2.93e-08 | 861 | 101 | 15 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ANK3 CACNA2D2 NEIL1 OBSCN HIPK2 CHD9 CEP192 GRHL2 ERBIN ALX4 KMT2C SHANK2 BRI3BP PTPRJ TULP4 ATXN1 TJP1 PIP5K1A ZMYM4 | 5.12e-08 | 1489 | 101 | 19 | 28611215 |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 12507281 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 19332538 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 24433183 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 10575001 | ||
| Pubmed | RBM15 ANK3 PKP4 NAGLU LMTK2 DAPK3 CEP192 CLPX ERBIN PTPRJ TJP1 YLPM1 NHS CBX8 GAB1 | 3.73e-07 | 1049 | 101 | 15 | 27880917 | |
| Pubmed | TCEA1 RBM15 RBM11 ESS2 TTLL5 ERBIN DST ADSL EPC1 PIP5K1A LRIF1 CBX8 | 3.97e-07 | 645 | 101 | 12 | 25281560 | |
| Pubmed | 4.38e-07 | 421 | 101 | 10 | 36976175 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 27861634 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 23685254 | ||
| Pubmed | 1.84e-06 | 197 | 101 | 7 | 36604605 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 11956313 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 8838651 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 22410172 | ||
| Pubmed | ANK3 DSCAM TBC1D22B CEP192 ERBIN CDKL5 FAT1 DST TJP1 OCLN GAB1 CDON | 2.75e-06 | 777 | 101 | 12 | 35844135 | |
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 3.27e-06 | 35 | 101 | 4 | 37381005 | |
| Pubmed | INPP5E KIF21A LMTK2 TUBGCP6 KMT2C DST DEPDC5 FAM149B1 ANKS3 ZMYM4 | 3.39e-06 | 529 | 101 | 10 | 14621295 | |
| Pubmed | RBM11 ESS2 NUMA1 HIPK2 CEP192 CLPX ERBIN HOXA5 KMT2C FAT1 DST ATXN1 EPC1 YLPM1 LRIF1 ZMYM4 | 3.60e-06 | 1429 | 101 | 16 | 35140242 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.83e-06 | 220 | 101 | 7 | 35785414 | |
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 18449193 | ||
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 19429912 | ||
| Pubmed | DLGAP1 ANK3 DSCAM KIF21A PKP4 NUMA1 ARHGEF12 DAPK3 ERBIN DST SHANK2 TJP1 YLPM1 | 4.47e-06 | 963 | 101 | 13 | 28671696 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.75e-06 | 430 | 101 | 9 | 35044719 | |
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 5.10e-06 | 39 | 101 | 4 | 16510873 | |
| Pubmed | 5.13e-06 | 12 | 101 | 3 | 10601346 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 6.43e-06 | 569 | 101 | 10 | 30639242 | |
| Pubmed | Myc regulates embryonic vascular permeability and remodeling. | 6.66e-06 | 13 | 101 | 3 | 19407242 | |
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 7.58e-06 | 43 | 101 | 4 | 18804439 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23220562 | ||
| Pubmed | PIP5K1α promotes myogenic differentiation via AKT activation and calcium release. | 8.35e-06 | 2 | 101 | 2 | 29426367 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28332063 | ||
| Pubmed | Use of surface plasmon resonance for real-time analysis of the interaction of ZO-1 and occludin. | 8.35e-06 | 2 | 101 | 2 | 11700038 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15548514 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23303682 | ||
| Pubmed | NuMA1 promotes axon initial segment assembly through inhibition of endocytosis. | 8.35e-06 | 2 | 101 | 2 | 31727776 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15994200 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30053339 | ||
| Pubmed | Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. | 8.35e-06 | 2 | 101 | 2 | 12741986 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7798316 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22711802 | ||
| Pubmed | Expression and distribution of ZO-3, a tight junction MAGUK protein, in mouse tissues. | 8.35e-06 | 2 | 101 | 2 | 14622136 | |
| Pubmed | Influence of protein kinase C on transcription of the tight junction elements ZO-1 and occludin. | 8.35e-06 | 2 | 101 | 2 | 15622522 | |
| Pubmed | Akt1 and akt3 exert opposing roles in the regulation of vascular tumor growth. | 8.35e-06 | 2 | 101 | 2 | 25388284 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19500214 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23711387 | ||
| Pubmed | Different expression of occludin and ZO-1 in primary and metastatic liver tumors. | 8.35e-06 | 2 | 101 | 2 | 18386163 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 9531559 | ||
| Pubmed | Interaction between Erbin and a Catenin-related protein in epithelial cells. | 8.35e-06 | 2 | 101 | 2 | 11711544 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20003786 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26272951 | ||
| Pubmed | Loss of Hoxa5 gene function in mice perturbs intestinal maturation. | 8.35e-06 | 2 | 101 | 2 | 10564089 | |
| Pubmed | Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung. | 8.35e-06 | 2 | 101 | 2 | 20980808 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27671373 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28731173 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23428392 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21777670 | ||
| Pubmed | NHS-A isoform of the NHS gene is a novel interactor of ZO-1. | 8.35e-06 | 2 | 101 | 2 | 19447104 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19017651 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16737969 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17243118 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18474622 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26863122 | ||
| Pubmed | ERBIN associates with p0071, an armadillo protein, at cell-cell junctions of epithelial cells. | 8.35e-06 | 2 | 101 | 2 | 12047349 | |
| Pubmed | Expression of ZO-1 and occludin in normal human placenta and in hydatidiform moles. | 8.35e-06 | 2 | 101 | 2 | 11228248 | |
| Pubmed | 8.36e-06 | 94 | 101 | 5 | 32062451 | ||
| Pubmed | 8.45e-06 | 14 | 101 | 3 | 23690951 | ||
| Pubmed | 1.30e-05 | 16 | 101 | 3 | 20978075 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.49e-05 | 377 | 101 | 8 | 38117590 | |
| Pubmed | GRHL2 Is Required for Collecting Duct Epithelial Barrier Function and Renal Osmoregulation. | 1.57e-05 | 17 | 101 | 3 | 29237740 | |
| Pubmed | Pericytes are required for blood-brain barrier integrity during embryogenesis. | 2.23e-05 | 19 | 101 | 3 | 20944625 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 2.50e-05 | 3 | 101 | 2 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 2.50e-05 | 3 | 101 | 2 | 38528080 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15987444 | ||
| Pubmed | Role of Akt isoforms in IGF-I-mediated signaling and survival in myoblasts. | 2.50e-05 | 3 | 101 | 2 | 19703413 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19825827 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16540465 | ||
| Pubmed | Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. | 2.50e-05 | 3 | 101 | 2 | 22632897 | |
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 2.50e-05 | 3 | 101 | 2 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 2.50e-05 | 3 | 101 | 2 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 2.50e-05 | 3 | 101 | 2 | 25037569 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 2.50e-05 | 3 | 101 | 2 | 29173281 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21590431 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 29235817 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 34296180 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 36946050 | ||
| Pubmed | CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma. | 2.50e-05 | 3 | 101 | 2 | 29066512 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19262140 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 2.50e-05 | 3 | 101 | 2 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 2.50e-05 | 3 | 101 | 2 | 24722238 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11557048 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 23568966 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19538286 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 25486565 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 24039187 | ||
| Interaction | OCLN interactions | UNC13B ANK3 PKP4 LMTK2 ARHGEF12 ERBIN ZFPL1 DST TJP1 LAMP3 NHS OCLN GAB1 TJP3 | 1.54e-07 | 500 | 99 | 14 | int:OCLN |
| Interaction | GJA1 interactions | ERBB4 ANK3 TAS1R3 PKP4 LMTK2 TBC1D22B ERBIN ZFPL1 DST TJP1 LAMP3 PIP5K1A AKT1 OCLN GAB1 | 1.59e-07 | 583 | 99 | 15 | int:GJA1 |
| Interaction | CDH1 interactions | ANK3 PKP4 ARHGEF12 TBC1D22B ERBIN CDKL5 DST SHANK2 PTPRJ TJP1 PAH NHS AKT1 OCLN GAB1 | 4.96e-06 | 768 | 99 | 15 | int:CDH1 |
| Interaction | AFDN interactions | 5.62e-06 | 333 | 99 | 10 | int:AFDN | |
| Interaction | CTNND1 interactions | 6.33e-06 | 265 | 99 | 9 | int:CTNND1 | |
| Interaction | ERBIN interactions | 6.33e-06 | 265 | 99 | 9 | int:ERBIN | |
| Interaction | SHANK2 interactions | 7.40e-06 | 55 | 99 | 5 | int:SHANK2 | |
| Interaction | IFNE interactions | 8.82e-06 | 27 | 99 | 4 | int:IFNE | |
| Interaction | FLOT1 interactions | ANK3 PCLO PKP4 LMTK2 ARHGEF12 ERBIN DST TJP1 OCLN TUBD1 GAB1 | 2.17e-05 | 475 | 99 | 11 | int:FLOT1 |
| Interaction | NUMBL interactions | 2.31e-05 | 116 | 99 | 6 | int:NUMBL | |
| Interaction | TOP3B interactions | UNC13B PLXNA3 RBM15 RBM11 INPP5E NAGLU OBSCN LMTK2 CEP192 CLPX BMP4 KMT2C FAT1 DST SHANK2 TULP4 CSPG4 AKT1 DEPDC5 TJP3 | 2.61e-05 | 1470 | 99 | 20 | int:TOP3B |
| Interaction | MAP4K4 interactions | 3.63e-05 | 254 | 99 | 8 | int:MAP4K4 | |
| Interaction | CBLN4 interactions | 3.86e-05 | 127 | 99 | 6 | int:CBLN4 | |
| Interaction | EPHA2 interactions | ERBB4 ANK3 PKP4 TBC1D22B ERBIN ZFPL1 DST LAMP3 PIP5K1A NHS AKT1 OCLN GAB1 | 5.00e-05 | 719 | 99 | 13 | int:EPHA2 |
| Interaction | TJP3 interactions | 5.01e-05 | 15 | 99 | 3 | int:TJP3 | |
| Interaction | TULP3 interactions | 5.20e-05 | 346 | 99 | 9 | int:TULP3 | |
| Interaction | EPB41L4A interactions | 6.66e-05 | 140 | 99 | 6 | int:EPB41L4A | |
| Interaction | TEC interactions | 8.16e-05 | 90 | 99 | 5 | int:TEC | |
| Interaction | CXADR interactions | 8.52e-05 | 369 | 99 | 9 | int:CXADR | |
| Interaction | RAPGEF4 interactions | 1.06e-04 | 50 | 99 | 4 | int:RAPGEF4 | |
| Interaction | KALRN interactions | 1.11e-04 | 96 | 99 | 5 | int:KALRN | |
| Interaction | ABI1 interactions | 1.16e-04 | 223 | 99 | 7 | int:ABI1 | |
| Interaction | CTNNB1 interactions | DLGAP1 ANK3 PKP4 NUMA1 RET ERBIN CDKL5 DST ADSL PTPRJ TJP1 NHS AKT1 OCLN CDON | 1.17e-04 | 1009 | 99 | 15 | int:CTNNB1 |
| Interaction | EBAG9 interactions | 1.25e-04 | 303 | 99 | 8 | int:EBAG9 | |
| Interaction | ARL13B interactions | 1.74e-04 | 318 | 99 | 8 | int:ARL13B | |
| Interaction | DLG1 interactions | 1.83e-04 | 240 | 99 | 7 | int:DLG1 | |
| Interaction | LRRC7 interactions | 1.90e-04 | 58 | 99 | 4 | int:LRRC7 | |
| Interaction | ARVCF interactions | 2.03e-04 | 59 | 99 | 4 | int:ARVCF | |
| Interaction | SPTBN2 interactions | 2.06e-04 | 172 | 99 | 6 | int:SPTBN2 | |
| Interaction | LYN interactions | RBM11 ERBB4 ANK3 PKP4 LMTK2 ERBIN DST LAMP3 PIP5K1A OCLN TUBD1 GAB1 | 2.12e-04 | 720 | 99 | 12 | int:LYN |
| Interaction | MARVELD2 interactions | 2.16e-04 | 60 | 99 | 4 | int:MARVELD2 | |
| Interaction | YWHAZ interactions | DLGAP1 RBM15 INPP5E TBC1D22B TACC2 CEP192 ERBIN DST ADSL ATXN1 TJP1 MAP3K9 FAM83G NHS AKT1 DEPDC5 GAB1 | 2.21e-04 | 1319 | 99 | 17 | int:YWHAZ |
| Interaction | CDKL5 interactions | 2.38e-04 | 113 | 99 | 5 | int:CDKL5 | |
| Interaction | CLDN1 interactions | 2.75e-04 | 26 | 99 | 3 | int:CLDN1 | |
| Interaction | ACBD3 interactions | 2.91e-04 | 259 | 99 | 7 | int:ACBD3 | |
| Interaction | PPP1R3A interactions | 2.95e-04 | 65 | 99 | 4 | int:PPP1R3A | |
| Interaction | YWHAH interactions | DLGAP1 RBM15 INPP5E LMTK2 DAPK3 TBC1D22B CEP192 ERBIN DST ATXN1 TJP1 MAP3K9 FAM83G NHS GAB1 | 3.04e-04 | 1102 | 99 | 15 | int:YWHAH |
| Interaction | DIRAS3 interactions | 3.12e-04 | 262 | 99 | 7 | int:DIRAS3 | |
| Interaction | KCNB2 interactions | 3.13e-04 | 66 | 99 | 4 | int:KCNB2 | |
| Interaction | LAMP1 interactions | PKP4 TBC1D22B ERBIN ZFPL1 CDKL5 DST MECR CSPG4 PIP5K1A DEPDC5 OCLN | 3.21e-04 | 644 | 99 | 11 | int:LAMP1 |
| Interaction | NEDD4 interactions | 3.43e-04 | 544 | 99 | 10 | int:NEDD4 | |
| Interaction | STX6 interactions | 3.62e-04 | 448 | 99 | 9 | int:STX6 | |
| Interaction | ZFPL1 interactions | 3.62e-04 | 448 | 99 | 9 | int:ZFPL1 | |
| Interaction | YWHAG interactions | DLGAP1 RBM15 INPP5E LMTK2 DAPK3 TBC1D22B CEP192 ERBIN DST ATXN1 TJP1 MAP3K9 FAM83G NHS AKT1 GAB1 | 3.67e-04 | 1248 | 99 | 16 | int:YWHAG |
| Interaction | DEPDC1B interactions | 3.72e-04 | 192 | 99 | 6 | int:DEPDC1B | |
| Interaction | SOSTDC1 interactions | 3.83e-04 | 29 | 99 | 3 | int:SOSTDC1 | |
| Interaction | STX7 interactions | ANK3 LMTK2 TBC1D22B ERBIN ZFPL1 DST PTPRJ LAMP3 PIP5K1A OCLN GAB1 | 3.90e-04 | 659 | 99 | 11 | int:STX7 |
| Interaction | YWHAE interactions | DLGAP1 RBM15 INPP5E DAPK3 TBC1D22B TACC2 ERBIN DST ATXN1 MAP3K9 FAM83G NHS PIMREG AKT1 DEPDC5 GAB1 | 3.94e-04 | 1256 | 99 | 16 | int:YWHAE |
| GeneFamily | PDZ domain containing | 3.42e-05 | 152 | 73 | 6 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 4.72e-04 | 160 | 73 | 5 | 555 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.42e-03 | 14 | 73 | 2 | 779 | |
| GeneFamily | Cadherin related | 2.10e-03 | 17 | 73 | 2 | 24 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 AKT3 ANK3 DSCAM INPP5E KIF21A TTLL5 PKP4 HIPK2 CEP192 LDLRAD3 ERBIN DST BRI3BP TULP4 YLPM1 GAB1 | 7.55e-07 | 1102 | 99 | 17 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 AKT3 ANK3 DSCAM INPP5E KIF21A TTLL5 PKP4 HIPK2 CEP192 LDLRAD3 ERBIN DST BRI3BP TULP4 YLPM1 GAB1 | 9.91e-07 | 1124 | 99 | 17 | MM1070 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.08e-05 | 199 | 99 | 7 | M5893 | |
| Coexpression | GSE13229_IMM_VS_INTMATURE_NKCELL_UP | 1.12e-05 | 200 | 99 | 7 | M3209 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.63e-05 | 212 | 99 | 7 | M39221 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 1.70e-05 | 389 | 99 | 9 | M39102 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 3.60e-05 | 240 | 99 | 7 | M39236 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | CAPN9 PLXNA3 ERBB4 ANK3 DSCAM HIPK2 RET GRHL2 CDKL5 FAT1 SHANK2 IGHE | 4.13e-05 | 786 | 99 | 12 | M10961 |
| Coexpression | PEREZ_TP53_TARGETS | ANK3 CACNA2D2 INPP5E OBSCN GRM8 GRHL2 HOXA5 TUBGCP6 PTPRJ CSPG4 CES3 FAM83G ATG4D GAB1 GABRA4 | 4.38e-05 | 1201 | 99 | 15 | M4391 |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_DN | 5.63e-05 | 55 | 99 | 4 | M17600 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | 7.25e-05 | 583 | 99 | 10 | M17454 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 1.05e-04 | 197 | 99 | 6 | M9569 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.30e-04 | 68 | 99 | 4 | MM803 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.37e-04 | 69 | 99 | 4 | M19523 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.41e-04 | 208 | 99 | 6 | M39233 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 CDKL5 SHANK2 LAMP3 OCLN TMC5 | 9.64e-13 | 199 | 100 | 11 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | UNC13B ERBB4 CACNA2D2 TACC2 GRHL2 CDKL5 SHANK2 LAMP3 OCLN TMC5 GAB1 | 9.64e-13 | 199 | 100 | 11 | 725610310e5c5fd7120c0be9acb55bf152026ddd |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 CDKL5 SHANK2 LAMP3 OCLN TMC5 | 9.64e-13 | 199 | 100 | 11 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | UNC13B DLGAP1 ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 SHANK2 LAMP3 TMC5 | 1.29e-11 | 184 | 100 | 10 | 369b82f793deab672204558ae4e112cfa5aa9ccc |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | UNC13B ERBB4 ANK3 CACNA2D2 PCLO TACC2 GRHL2 SHANK2 LAMP3 TMC5 | 1.86e-11 | 191 | 100 | 10 | 276455a64c2c3503d5048615762eb2ee37f0ac70 |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 SHANK2 LAMP3 OCLN TMC5 | 1.86e-11 | 191 | 100 | 10 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 SHANK2 LAMP3 OCLN TMC5 | 1.96e-11 | 192 | 100 | 10 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.96e-11 | 192 | 100 | 10 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 SHANK2 LAMP3 OCLN TMC5 | 1.96e-11 | 192 | 100 | 10 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | UNC13B ERBB4 ANK3 CACNA2D2 TACC2 GRHL2 CDKL5 SHANK2 LAMP3 TMC5 | 2.80e-11 | 199 | 100 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-10 | 173 | 100 | 9 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.39e-10 | 188 | 100 | 9 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.29e-10 | 192 | 100 | 9 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-10 | 193 | 100 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.54e-10 | 193 | 100 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 6.07e-10 | 195 | 100 | 9 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 6.07e-10 | 195 | 100 | 9 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.07e-10 | 195 | 100 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-10 | 200 | 100 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.44e-09 | 168 | 100 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.69e-09 | 183 | 100 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.07e-09 | 184 | 100 | 8 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-08 | 187 | 100 | 8 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.07e-08 | 188 | 100 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-08 | 189 | 100 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-08 | 190 | 100 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-08 | 191 | 100 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-08 | 191 | 100 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.21e-08 | 191 | 100 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.26e-08 | 192 | 100 | 8 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.26e-08 | 192 | 100 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-08 | 192 | 100 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.37e-08 | 194 | 100 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-08 | 194 | 100 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-08 | 194 | 100 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-08 | 194 | 100 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-08 | 195 | 100 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.43e-08 | 195 | 100 | 8 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-08 | 196 | 100 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-08 | 198 | 100 | 8 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-08 | 198 | 100 | 8 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-08 | 200 | 100 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.33e-08 | 159 | 100 | 7 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 8.68e-08 | 163 | 100 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.16e-07 | 170 | 100 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-07 | 179 | 100 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.71e-07 | 180 | 100 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.77e-07 | 181 | 100 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.91e-07 | 183 | 100 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.06e-07 | 185 | 100 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.06e-07 | 185 | 100 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-07 | 186 | 100 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.13e-07 | 186 | 100 | 7 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.13e-07 | 186 | 100 | 7 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.21e-07 | 187 | 100 | 7 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.21e-07 | 187 | 100 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-07 | 188 | 100 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 2.29e-07 | 188 | 100 | 7 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-07 | 189 | 100 | 7 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-07 | 189 | 100 | 7 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.46e-07 | 190 | 100 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.46e-07 | 190 | 100 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 191 | 100 | 7 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-07 | 191 | 100 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.64e-07 | 192 | 100 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-07 | 193 | 100 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-07 | 193 | 100 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-07 | 193 | 100 | 7 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 194 | 100 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 194 | 100 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.84e-07 | 194 | 100 | 7 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-07 | 194 | 100 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.94e-07 | 195 | 100 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.94e-07 | 195 | 100 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 195 | 100 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-07 | 196 | 100 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-07 | 196 | 100 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.04e-07 | 196 | 100 | 7 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.04e-07 | 196 | 100 | 7 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-07 | 196 | 100 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-07 | 197 | 100 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-07 | 198 | 100 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-07 | 199 | 100 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-07 | 199 | 100 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 100 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-07 | 200 | 100 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-07 | 200 | 100 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 100 | 7 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 100 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.49e-06 | 157 | 100 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.79e-06 | 162 | 100 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-06 | 166 | 100 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-06 | 167 | 100 | 6 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-06 | 167 | 100 | 6 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-06 | 168 | 100 | 6 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-06 | 168 | 100 | 6 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-06 | 170 | 100 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.19e-06 | 179 | 100 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.19e-06 | 179 | 100 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; PC3; HT_HG-U133A | 2.18e-07 | 199 | 99 | 9 | 6658_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 8.23e-07 | 171 | 99 | 8 | 7535_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.38e-06 | 197 | 99 | 8 | 7012_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HT_HG-U133A | 2.47e-06 | 198 | 99 | 8 | 2489_UP | |
| Drug | AC1L9LT0 | 1.64e-05 | 123 | 99 | 6 | CID000448294 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.71e-05 | 186 | 99 | 7 | 3902_DN | |
| Drug | BX912 | 1.87e-05 | 2 | 99 | 2 | CID011754511 | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.03e-05 | 191 | 99 | 7 | 5917_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.17e-05 | 193 | 99 | 7 | 2131_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 195 | 99 | 7 | 6244_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 3711_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 99 | 7 | 6765_DN | |
| Drug | Scopoletin [92-61-5]; Up 200; 20.8uM; HL60; HT_HG-U133A | 2.73e-05 | 200 | 99 | 7 | 3131_UP | |
| Drug | Cgp77675 | 3.64e-05 | 43 | 99 | 4 | CID005311381 | |
| Drug | Bx 7 | 5.60e-05 | 3 | 99 | 2 | CID010077147 | |
| Drug | phenylacetylglycine | 5.60e-05 | 3 | 99 | 2 | CID000068144 | |
| Drug | 2,2',4,6,6'-pentachlorobiphenyl | 8.62e-05 | 20 | 99 | 3 | ctd:C417207 | |
| Drug | SU 5402 | 9.68e-05 | 55 | 99 | 4 | ctd:C105686 | |
| Drug | Li-8 | 1.12e-04 | 4 | 99 | 2 | CID000657138 | |
| Drug | N-benzyl-N-hydroxy-5-phenylpentamide | 1.33e-04 | 23 | 99 | 3 | CID000157806 | |
| Drug | 1,3-D | 1.51e-04 | 24 | 99 | 3 | CID000024726 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.64e-04 | 186 | 99 | 6 | 4463_UP | |
| Drug | Su 4984 | 1.86e-04 | 5 | 99 | 2 | CID000005306 | |
| Drug | C75; Down 200; 10uM; PC3; HT_HG-U133A | 1.89e-04 | 191 | 99 | 6 | 6399_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 4268_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 6958_UP | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 6400_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.06e-04 | 194 | 99 | 6 | 862_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 2893_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 6833_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 2238_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 5330_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 2264_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 6786_DN | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 6158_UP | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 6889_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 4415_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 3567_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; HL60; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 2726_UP | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3385_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4233_DN | |
| Drug | 0393-0188; Down 200; 10uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 7536_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3351_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4822_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 5630_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 6949_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 2732_UP | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 2.30e-04 | 198 | 99 | 6 | 621_DN | |
| Drug | WY-14643; Down 200; 100uM; MCF7; HG-U133A | 2.30e-04 | 198 | 99 | 6 | 368_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 4333_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6790_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6812_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 5476_DN | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 2281_DN | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6800_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 1158_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6763_UP | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 3072_DN | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6257_UP | |
| Drug | sulindac; Up 200; 100uM; MCF7; HG-U133A | 2.30e-04 | 198 | 99 | 6 | 168_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 5628_UP | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 5673_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6040_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 2514_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4725_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 1470_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4988_UP | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4659_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 3678_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 6033_DN | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 5415_UP | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4140_UP | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 3564_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 2.42e-04 | 200 | 99 | 6 | 3776_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.42e-04 | 200 | 99 | 6 | 3549_UP | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.91e-05 | 49 | 95 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 2.64e-05 | 268 | 95 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 4.60e-05 | 121 | 95 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 9.76e-05 | 74 | 95 | 4 | DOID:3748 (is_marker_for) | |
| Disease | melanoma | 1.54e-04 | 248 | 95 | 6 | C0025202 | |
| Disease | Neurodevelopmental Disorders | 2.36e-04 | 93 | 95 | 4 | C1535926 | |
| Disease | Adenocarcinoma of large intestine | 2.67e-04 | 96 | 95 | 4 | C1319315 | |
| Disease | Unilateral agenesis of kidney | 2.84e-04 | 8 | 95 | 2 | C0266294 | |
| Disease | Cutaneous Melanoma | 3.15e-04 | 41 | 95 | 3 | C0151779 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.37e-04 | 102 | 95 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 3.39e-04 | 42 | 95 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | creatinine measurement | DSCAM OBSCN CHD9 DAPK3 GRHL2 CDKL5 BMP4 ADSL PTPRJ CSPG4 PIP5K1A | 3.58e-04 | 995 | 95 | 11 | EFO_0004518 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.16e-04 | 45 | 95 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | breast carcinoma | ERBB4 LMTK2 ARHGEF12 TACC2 CEP192 GRHL2 ALX4 ATXN1 ANKRD30A CBX8 GAB1 | 4.37e-04 | 1019 | 95 | 11 | EFO_0000305 |
| Disease | Colorectal Carcinoma | 4.41e-04 | 702 | 95 | 9 | C0009402 | |
| Disease | Joubert syndrome (is_implicated_in) | 4.54e-04 | 10 | 95 | 2 | DOID:0050777 (is_implicated_in) | |
| Disease | Polydactyly | 5.66e-04 | 117 | 95 | 4 | C0152427 | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | tuberculosis | 6.81e-04 | 216 | 95 | 5 | MONDO_0018076 | |
| Disease | Small cell carcinoma of lung | 7.12e-04 | 54 | 95 | 3 | C0149925 | |
| Disease | unipolar depression, mood disorder | 9.40e-04 | 134 | 95 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | Tremor, Rubral | 1.20e-03 | 16 | 95 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.20e-03 | 16 | 95 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.20e-03 | 16 | 95 | 2 | C0278161 | |
| Disease | infant expressive language ability | 1.20e-03 | 16 | 95 | 2 | EFO_0006316 | |
| Disease | Ataxia, Sensory | 1.20e-03 | 16 | 95 | 2 | C0240991 | |
| Disease | nervousness | 1.20e-03 | 16 | 95 | 2 | NCIT_C74532 | |
| Disease | Abnormal coordination | 1.20e-03 | 16 | 95 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.20e-03 | 16 | 95 | 2 | C0427190 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.50e-03 | 152 | 95 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.58e-03 | 261 | 95 | 5 | C0004352 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.88e-03 | 20 | 95 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.93e-03 | 163 | 95 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 2.07e-03 | 78 | 95 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Anophthalmia-microphthalmia syndrome | 2.07e-03 | 21 | 95 | 2 | cv:C5680330 | |
| Disease | Schizophrenia | 2.19e-03 | 883 | 95 | 9 | C0036341 | |
| Disease | Primary microcephaly | 2.27e-03 | 22 | 95 | 2 | C0431350 | |
| Disease | Malignant neoplasm of breast | 2.41e-03 | 1074 | 95 | 10 | C0006142 | |
| Disease | malignant astrocytoma (is_marker_for) | 2.48e-03 | 23 | 95 | 2 | DOID:3069 (is_marker_for) | |
| Disease | neuroticism measurement | 2.66e-03 | 909 | 95 | 9 | EFO_0007660 | |
| Disease | triacylglycerol 56:4 measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0010431 | |
| Disease | stomach carcinoma (is_marker_for) | 2.70e-03 | 24 | 95 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Ataxia | 2.93e-03 | 25 | 95 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVSSVPSRAQSPSYV | 211 | Q99569 | |
| YSPVSQSREGSSPFR | 21 | Q9H161 | |
| VDSERRPHFPQFSYS | 461 | P31749 | |
| QRYSADPTVFAPERS | 1126 | Q15303 | |
| DFNYSRTSPSKRPNA | 1161 | Q96RT1 | |
| GSSTNDPYVAFRRRT | 201 | Q9H2F5 | |
| QYFSPASVSSSPARA | 111 | Q8WY22 | |
| ASLDFATEPYNAARP | 2156 | Q6UVK1 | |
| NPEPFNASFYRRSLD | 781 | Q9NY47 | |
| RAPLRSFTETPAYFA | 51 | O76031 | |
| ERPSPFSQLVYTSND | 16 | Q9BXX3 | |
| PAQRAASATASPFFR | 761 | Q96C12 | |
| FSDPLASSTFPRRHY | 61 | O14490 | |
| SPSDYSSRDPSGVRA | 366 | P54253 | |
| YPERPASRANTVRSF | 106 | P12644 | |
| DNERRPHFPQFSYSA | 461 | Q9Y243 | |
| FPRYRTASQGPQTDS | 1281 | Q9NZN5 | |
| SAPSLATSPAFRYDL | 546 | P54802 | |
| NVQYRFGSSRSSEPA | 81 | P57052 | |
| RSTRTAATSVPAYEP | 596 | Q96T37 | |
| LTSPVDDFRQPRYSS | 356 | Q16625 | |
| FVRSPRTASSAFYPQ | 1096 | O75140 | |
| LPSRPASYASRHSSF | 1316 | O75140 | |
| DTNDLRPLFSPTSYS | 141 | Q14517 | |
| SFSRYSDAVSLPQDP | 956 | Q12913 | |
| PPYRSRSGSANSASS | 291 | Q86YD5 | |
| TFSRVSPSAARDPYD | 2286 | Q8NEZ4 | |
| TTRFFNRDTDSPYPL | 431 | Q9H2X6 | |
| ESQRASYPSSPASAV | 61 | A8MXT2 | |
| AQSPLQRPVSSFFSY | 771 | O60732 | |
| PIFQPASSSNYFLTR | 96 | Q5T3J3 | |
| SVSRNPEVPFESSAY | 31 | Q96FI4 | |
| NPYRSSAADVTTRFD | 456 | Q9NRR6 | |
| TNRDSPIFDYSPRLS | 2211 | Q03001 | |
| YDIPRAFPSDRSSSL | 406 | Q13480 | |
| SFPVSDISQAYRSAP | 631 | Q8ND23 | |
| SPTADESSRAPFQYT | 3686 | Q9Y6V0 | |
| ARSLNRSSFTYYPDP | 1111 | P51805 | |
| RSYAASASAAPAEPR | 71 | P20719 | |
| SSLPPNNSYADFERF | 311 | O43293 | |
| RAKAFPETRDYSQPT | 26 | Q9UQV4 | |
| APYSRFSISPANIAS | 1466 | Q8IWU2 | |
| RSYLASSPNPFSRAN | 426 | P48169 | |
| SEDPRRQPSKVSSYA | 101 | Q96CW5 | |
| ASTQPSRPQEYDFST | 941 | Q96RT7 | |
| AAFRSPYSSTEPLCS | 181 | Q9BSJ6 | |
| NTRYDFFSRVVPPDS | 186 | O00222 | |
| SSETQYSVDTRRPAP | 341 | Q99755 | |
| NFAATIPRPFSVRYD | 401 | P00439 | |
| SPLARSYPNRDAEST | 496 | Q5XG87 | |
| SATFRCRISPANYEP | 3021 | Q5VST9 | |
| DRALRASYTPSPARS | 411 | Q96DF8 | |
| PSARRSYDANTVASF | 2281 | Q3L8U1 | |
| PPFNTRRAYTSEDEA | 21 | Q6ISB3 | |
| YPGRSPQDLASTSRA | 106 | Q9HC52 | |
| RSSASRPYQVVGFPN | 806 | Q4KMG0 | |
| SPLRSYVSAAPSAFQ | 1776 | Q12955 | |
| YVSAAPSAFQSLRTP | 1781 | Q12955 | |
| DSNPRGVSAYLSRPS | 211 | P01854 | |
| NQGTSDFLPSRPRYS | 271 | P28300 | |
| FLAESSPQTQRAPYS | 411 | Q6ZW76 | |
| STPSDSYSSVRNPRI | 901 | Q8TEP8 | |
| ASSYSASAEPARVRA | 31 | Q9BV79 | |
| RGASRPNPQEFTYSS | 436 | Q96LA5 | |
| DKRSSLYFPRSPSAN | 671 | O94868 | |
| PTVSFSRYLRDSGSP | 421 | Q6UWW8 | |
| SNSSLFYSERPQIPF | 51 | O14815 | |
| AQIAEPSTSRYFPSS | 506 | O76039 | |
| FPSNYVTPRSAFSSR | 106 | P80192 | |
| YSTRSAPASQASLRA | 1836 | Q14980 | |
| RLYPRSPSAVSASYE | 156 | Q96BN6 | |
| GPPRYRSAADSVQSS | 716 | A6ND36 | |
| YDSSDRPSRIPERFS | 66 | A0A0A0MS00 | |
| SFPISPSERSYRLEN | 1426 | O60469 | |
| SRGSFIPARYNSSRA | 191 | P84550 | |
| PERSQSTTSDVPANY | 111 | Q9NU19 | |
| APPAASSSRYSVRCR | 1606 | Q6T4R5 | |
| DSYRSPLASRYASPE | 11 | P30566 | |
| NARDTYVSSFPRAPS | 121 | P23193 | |
| RFATSTIQPPREYSS | 556 | O94993 | |
| SGPAAPAQSYTALFR | 271 | Q8WZ75 | |
| DYESRTSGTRRAPSP | 1696 | Q9UPX8 | |
| PAAAQYRSSSPEDAR | 6 | Q86TL0 | |
| QSVPTASSARAGRYP | 6 | Q9UBN6 | |
| PRFSGRQFPNYSSEL | 81 | A0A5A2 | |
| PTYSAESSFHYRRNP | 241 | Q9UJT1 | |
| SSYSLLSPPDSARDR | 1066 | Q9NRJ4 | |
| ARETFPSFFRTVPSD | 176 | Q7RTX0 | |
| AYRAPASAAASEDAP | 581 | P41226 | |
| NLTRATARAPYFSGS | 506 | Q7Z4S6 | |
| SSREESPEPYFFRRT | 1031 | Q5VZP5 | |
| TATYTSSQNRPRADP | 231 | Q6UXI7 | |
| AAAFPAERDSSTPYQ | 151 | O95359 | |
| DYPERRAISPTSSSR | 246 | O14795 | |
| ARFATTSYSRPCTDN | 241 | Q8N841 | |
| LYNREDRFSAPPSRS | 1241 | P49750 | |
| FRRPAQAFPVSYSSS | 676 | P07949 | |
| QAFPVSYSSSGARRP | 681 | P07949 | |
| SRSYEQVPPQGFTSR | 1196 | Q07157 | |
| PRESSYDIYRVPSSQ | 356 | O95049 | |
| RSNPYSVASRTRPDY | 51 | Q6UXY8 | |
| DSASAAPAFYSQAPR | 171 | O95159 | |
| QTPETNFRDSSYPFA | 216 | Q5VZL5 | |
| ASTRPIYPTFESSRR | 406 | Q6EMB2 |